• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

F1000 Research joins Taylor & Francis Group

Bioengineer by Bioengineer
January 10, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Taylor & Francis and F1000 Research Ltd.


Leading specialist academic publisher Taylor & Francis Group, part of Informa plc, has today announced the addition of cutting-edge open research publisher F1000 Research Ltd.

United by their shared goals of amplifying and democratizing research, the addition is an important further step in strengthening Taylor & Francis’ capabilities in open access and open research and extending its range of innovative publishing services.

“The addition of F1000 Research significantly strengthens and extends our capabilities in open research and broader publishing services. It also brings with it a strong culture of innovation and challenging the status quo. This will be invaluable as we evolve to meet the research needs of the 21st century; offering options to create the impact needed to convert research into solutions quickly,” says Annie Callanan, Chief Executive of Taylor & Francis.

F1000 Research is a trail-blazer in the evolution of research communication. In 2013, it launched the world’s first open research publishing platform, combining the opportunities offered by technology with a passion for identifying new ways to validate and share research.

F1000 Research’s publishing model combines the benefits of pre-printing, including the ability to publish rapidly, with functionality that ensures the robustness, quality, reproducibility and transparency of research through rigorous editorial checks, open data support and invited open peer review. Authors are provided with autonomy throughout the publishing process.

Building upon the growth and success of its core platform, F1000 Research also provides fully managed, open research publishing services directly to research funders and institutions, including Wellcome, the Bill & Melinda Gates Foundation and the Health Research Board Ireland, as well as to other scholarly publishers such as Emerald Publishing. F1000 Research combines opportunities offered by technology with a passion for identifying new ways to validate and share research.

Taylor & Francis will provide investment, expertise and ongoing support to enable F1000 Research to continue to develop its range of publishing services, supporting continued innovation in scholarly communication and accelerating impact across the whole research ecosystem.

Rebecca Lawrence, Managing Director, F1000 Research Ltd said:

“Having the expertise and support of a large, historic and established publisher will strengthen our ability to innovate in scholarly communications, bringing benefits to the whole research ecosystem. We will be super-charged with the resources not only to maintain our philosophy and collaborative partnership approach, but to grow, flourish and continue to innovate in support of our shared commitments to customers on speed, transparency, quality and impact.”

The move also opens up new opportunities to connect the humanities and science communities who currently partner with Routledge and Taylor & Francis to F1000 Research’s innovative services.

Whilst continuing to operate independently, F1000 Research will become a key component of Taylor & Francis’s range of open research services and Plan S-compliant platforms, complementing its extensive and growing portfolio of Open Access journals and supporting the company’s ethos of evolving to deliver what researchers across the world expect by championing choice, whatever their field of research or source of funding.

Vitek Tracz, founder of F1000 Research and Chairman of Science Navigation Group said:

“The default way for researchers to share their findings, the Research Journal, is evolving. F1000 Research proposed an efficient, transparent mechanism to respond to the rapidly growing range of needs and opportunities in the way information is shared. The task now needs input and support from a more established partner and I am happy that in the leadership of Taylor & Francis and Informa, we have found a team who understands and is committed to continuing this evolution.”

F1000Prime and F1000Workspace are not included in this transaction and will continue under the ownership of Vitek Tracz.

###

Media Contact
Jodie Bell
[email protected]
020-701-76571

Original Source

https://newsroom.taylorandfrancisgroup.com/f1000-research-joins-taylor-francis/

Tags: Medicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Insights on Menstrual Health in Eating Disorder Units

September 12, 2025

Nicotine Dependence Linked to Health Behaviors in Korean Smokers

September 12, 2025

Salvia Spinosa’s Antimicrobial Effect on Enterococcus faecalis

September 12, 2025

Choosing Wisely: A Challenge in Clinical Reasoning

September 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Insights on Menstrual Health in Eating Disorder Units

Nicotine Dependence Linked to Health Behaviors in Korean Smokers

Novel V2O5/ZnO Nanocomposite Electrodes for Energy Storage

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.